Showing results (261-270 of 631) with videos related to

Sort By:
Pageof 64
European Journal of Biochemistry|September 15, 1994
Characterization of the murine plasma fibrinolytic systemH R Lijnen, B van Hoef, V Beelen, et al.
Circulation|June 1, 1991
Small animal thrombosis models for the evaluation of thrombolytic agentsJ M Stassen, H R Lijnen, L Kieckens, et al.
Thrombosis Research|February 1, 1990
Effect of fibrin-targeting on clot lysis with urokinase-type plasminogen activatorH R Lijnen, M Dewerchin, F De Cock, et al.
Thrombosis and Haemostasis|August 31, 1984
Biological and thrombolytic properties of proenzyme and active forms of human urokinase--I. Fibrinolytic and fibrinogenolytic properties in human plasma in vitro of urokinases obtained from human urine or by recombinant DNA technologyC Zamarron, H R Lijnen, B Van Hoef, et al.
The Journal of Biological Chemistry|August 9, 1996
Effects of deletion of the carboxyl-terminal domain of ApoA-I or of its substitution with helices of ApoA-II on in vitro and in vivo lipoprotein associationP Holvoet, Z Zhao, E Deridder, et al.
Thrombosis and Haemostasis|January 23, 1992
An enzyme-linked immunosorbent assay for urokinase-type plasminogen activator (u-PA) and mutants and chimeras containing the serine protease domain of u-PAP J Declerck, L Van Keer, M Verstreken, et al.
European Journal of Clinical Investigation|February 1, 1977
A latex agglutination test for rapid quantitative estimation of the plasmin-antipalsmin complex in human plasmaD Collen, F de Cock, C L Cambiaso, et al.
The Journal of Biological Chemistry|August 5, 1987
Characterization of a fusion protein consisting of amino acids 1 to 263 of tissue-type plasminogen activator and amino acids 144 to 411 of urokinase-type plasminogen activatorL Nelles, H R Lijnen, D Collen, et al.
Biochimica Et Biophysica Acta|July 10, 2007
Inhibition of vascular endothelial growth factor receptor tyrosine kinases impairs adipose tissue development in mouse models of obesityH R Lijnen, B Van Hoef, D Kemp, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1987
Pharmacokinetics of single chain forms of urokinase-type plasminogen activatorD C Stump, L Kieckens, F De Cock, et al.
Pageof 64